Peru vs Qatar: Treatment success rate for patients treated for MDR-TB
Peru
57.0%
in 2022
Qatar
56.0%
in 2022
Peru rank
129th
Qatar rank
132nd
Treatment success rate for patients treated for MDR-TB over time
- Peru
- Qatar
How they compare
Peru currently reports 57.0% against 56.0% in Qatar, a difference of 1.0%.
The two have swapped places 4 times across 11 shared years of data; in 2007 it was Peru ahead.
Peru ranks 129th and Qatar ranks 132nd of 163 countries.
Across the 3 decades both report, Peru averaged higher in 2 and Qatar in 1.
Head to head by decade
| Decade | Peru | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.3% | 0.0% | 33.3% | Peru |
| 2010s | 59.5% | 33.7% | 25.8% | Peru |
| 2020s | 60.5% | 61.5% | 1.0% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Peru or Qatar?
- Peru, at 57.0% against 56.0% in Qatar as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Peru and Qatar?
- 1.0%, with Peru ahead.
- How many years of comparable data are there for Peru and Qatar?
- 11 years are reported by both, from 2007 to 2022.
- How do Peru and Qatar rank globally for treatment success rate for patients treated for mdr-tb?
- Peru ranks 129th and Qatar ranks 132nd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.